Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Oxford BioDynamics ( (GB:OBD) ) has shared an announcement.
Oxford BioDynamics plc announced the successful completion of its fundraising activities, raising approximately £7.35 million through the WRAP Retail Offer, Placing, and Subscriptions. This capital infusion will facilitate the issuance of nearly 1.47 billion new Ordinary Shares, with admission to the AIM market expected on 4 February 2025, pending shareholder approval. The proceeds will support the company’s further development and operational activities, strengthening its position in the precision diagnostics industry.
More about Oxford BioDynamics
Oxford BioDynamics plc is a precision clinical diagnostics company that utilizes its EpiSwitch® 3D genomics platform to develop specific and sensitive tests for medical practice. The company focuses on advancing the field of precision medicine through innovative genomic solutions.
YTD Price Performance: -62.13%
Average Trading Volume: 3,871,472
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £1.92M
See more data about OBD stock on TipRanks’ Stock Analysis page.
